Respiratory Disorders Market in United States, Forecast to 2022
Respiratory Disorders Market in United States, Forecast to 2022
Huge Gaps and Unmet Needs Across the Care Continuum Provide Opportunities for Companies to Realize Market Potential
27-Dec-2019
North America
Market Research
$3,000.00
Special Price $2,250.00 save 25 %
Description
Global resource constraints on health systems are driving a shift to value-based healthcare to reduce cost, increase access, and improve outcomes. In the United States, resource constraints affect more than 20% of the population. The number of respiratory therapists is declining at a rate of 4% to 7%, while the demand for respiratory specialists will increase by 35% by 2020. The role of respiratory therapists is critical in keeping patients out of emergency or hospital care. In the United States, nearly 15% of all primary care visits, or more than 125 million patient visits alone, are for respiratory related conditions. Within respiratory diseases, 4 conditions primarily contribute to the high burden of respiratory disease. These include asthma, chronic obstructive pulmonary disease (COPD), respiratory tract infections (RTI), and lung cancer. More than 100 million people are affected by respiratory disease in the United States, which highlights the staggering magnitude of the burden of respiratory /lung disease. The demand-supply gap for resources is expected to widen further with the increase in incidence rates of respiratory diseases.
Though respiratory disease is one of the leading causes of morbidity and mortality among non-communicable diseases, most major respiratory conditions are preventable. Much of the respiratory conditions can be mitigated by improved screening and early diagnosis of patients/public, especially in the smoking population. Government agencies and respiratory associations are strategizing measures to reduce the burden of respiratory and sleep related disorders to have a profound effect on the respiratory health for patients, reduce economic costs, and improve the quality of life for people. Screening/diagnosis and monitoring account for only 16% of the total spending on respiratory care. A major portion, or more than 60%, of the healthcare spending is still in treatment. Investment trends show that patient medication adherence and monitoring remains the most attractive domain within respiratory care. However, little emphasis was laid on diagnosis/screening, which remains one of the primary unmet needs in the respiratory care continuum. Screening and patient medication adherence remain key market growth opportunities for OEMs within the respiratory care industry.
This research service provides an overview on the unmet needs and gaps in the respiratory disease sector and provides details on investment/funding in the respiratory sector. The unique value of this study is that it provides insights, challenges, and unmet needs for 10 major respiratory and sleep apnea conditions. This research also identifies growth opportunities by care continuum and technologies within sleep and respiratory care.
Author: Sowmya Rajagopalan
Table of Contents
Current Spending on Respiratory Care in the United States
Respiratory Care Spending by Care Continuum
Investment Landscape in Sleep and Respiratory Disease Sector by Clinical Applications
Focus of OEMs in Sleep and Respiratory Disorders
Spending on Sleep and Respiratory Disorders—Summary
Trends Shaping the Sleep and Respiratory Care Industry
Sleep and Respiratory Disease Burden in the United States
Spending on Sleep and Respiratory Disorders—Summary
Overview of Lung Cancer—Disease Burden and Spending by Care Continuum
Lung Cancer—Unmet Needs and Opportunity Analysis
Scenario Analysis—Lung Cancer Screening Population Analysis
Overview of COPD—Disease Burden and Spending by Care Continuum
COPD—Unmet Needs and Opportunity Analysis
Scenario Analysis—COPD Medication Adherence Analysis
Overview of Cystic Fibrosis—Disease Burden and Spending by Care Continuum
Cystic Fibrosis—Unmet Needs and Opportunity Analysis
Overview of Asthma—Disease Burden and Spending by Care Continuum
Asthma—Unmet Needs and Opportunity Analysis
Scenario Analysis—Asthma Medication Adherence Analysis
Overview of Pulmonary Fibrosis—Disease Burden and Spending by Care Continuum
Pulmonary Fibrosis—Unmet Needs and Opportunity Analysis
Overview of PE—Disease Burden and Spending by Care Continuum
PE—Unmet Needs and Opportunity Analysis
Scenario Analysis—PE Medication Adherence Analysis
Overview of RTI—Disease Burden and Spending by Care Continuum
RTI—Unmet Needs and Opportunity Analysis
Overview of Chronic Bronchitis—Disease Burden and Spending by Care Continuum
Chronic Bronchitis—Unmet Needs and Opportunity Analysis
Overview of Sleep Apnea—Disease Burden and Spending by Care Continuum
Sleep Apnea—Unmet Needs and Opportunity Analysis
Scenario Analysis—Sleep Apnea Treatment Adherence Analysis
Overview of Pneumonia—Disease Burden and Spending by Care Continuum
Pneumonia—Unmet Needs and Opportunity Analysis
Overview of Pleural Effusion—Disease Burden and Spending by Care Continuum
Pleural Effusion—Unmet Needs and Opportunity Analysis
Resource and Infrastructure Analysis in the United States
Programs and Long-term Plans by Respiratory Disease Types
Programs and Long-term Plans by Respiratory Disease Types (continued)
Top-level Snapshot of Funding by Care Continuum
Top-level Snapshot of Funding by Technologies
Focus of OEMs in Sleep and Respiratory Disorders
Select List of Start-up Companies
Select List of Start-up Companies (continued)
Select List of Start-up Companies (continued)
Select List of Start-up Companies (continued)
Select List of Start-up Companies (continued)
Select List of Start-up Companies (continued)
Select List of Start-up Companies (continued)
Select List of Start-up Companies (continued)
Select List of Start-up Companies (continued)
Game Changers or Start-ups Disrupting Respiratory Industry—List of Companies
Current and Recommended Business Models
Technology 1—Respiratory Airway Clearance Vest
Technology 2—Digital Capnography (Tidal Breathing CO2) Diagnostic and Monitoring Device for Home Care
Technology 3—Smartphone-enabled or Connected Spirometers
Technology 4—Continuous Respiratory Rate Monitoring
Technology 5—Implantable Nerve Stimulator for Sleep Apnea
Technology 6—Oral Appliances for Sleep Apnea
Technology 7—Miniaturized CPAP
Technology 8—Smart Inhalers/Sensors
Technology 9—Respiratory Dialysis System (ECCO₂R Therapy)
Technology 10—Breath Analyzer for Non-invasive Lung Cancer Screening
Technology 11—AI to Process Patients’ Medical Imaging
Technology 12—Patient Management Apps
Technology 13—Wearable Devices
Technology 14—Lung Perfusion System
Technology 15—Assistive Robots
Product/Technology Pipeline in Sensor-based Technologies in Respiratory and Sleep Diseases, 2018
Analysis of M&A Deals in the Global Respiratory Device Industry
Mergers and Acquisitions
Mergers and Acquisitions (continued)
Mergers and Acquisitions (continued)
Mergers and Acquisitions (continued)
Royal Philips—M&A Strategy
Apax Medical—M&A Strategy
Key M&As Discussion
Key M&As Discussion (continued)
Key M&As Discussion (continued)
Key M&As Discussion (continued)
Select Partnerships and Collaborations in Respiratory and Sleep Disorders
Select Partnerships and Collaborations in Respiratory and Sleep Disorders (continued)
Select Partnerships and Collaborations in Respiratory and Sleep Disorders (continued)
Select Partnerships and Collaborations in Respiratory and Sleep Disorders (continued)
Select Partnerships and Collaborations in Respiratory and Sleep Disorders (continued)
Leading OEMs in Respiratory Sector Continue to Ignore Screening and Early Diagnosis
Shifting Care Delivery in Sleep and Respiratory Industry
Growth Opportunity by Technologies in the Sleep and Respiratory Industry
Select Sleep and Respiratory Technologies Impact by Care Settings
Select Sleep and Respiratory Technologies Impact by Care Settings (continued)
Growth Opportunity Areas for Companies
Growth Opportunity—Collaborations and Partnerships Among Vendors
Strategic Imperatives
Future Trends in the Sleep and Respiratory Care Industry
Growth Opportunities in Sleep and Respiratory Sector by Services/Solutions
Analyst Perspective
3 Big Predictions
Strategic Imperative and Growth Opportunities for Companies
Legal Disclaimer
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
The Frost & Sullivan Story
Value Proposition—Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
Deliverable Type | Market Research |
---|---|
No Index | No |
Podcast | No |
Author | Sowmya Rajagopalan |
Industries | Healthcare |
WIP Number | ME0E-01-00-00-00 |
Is Prebook | No |
GPS Codes | 9600-B1,9A47-B1,9A4B-B1 |